Abbott’s $21bn Bet on Exact Sciences Takes Center Stage at ASCO 2026
From Abbott's multi-cancer blood test to AI pathology platforms from Artera and Lunit, the data out of ASCO this week reframe diagnostics not as a prelude to care, but as its engine.
Medtech Insight - May 28, 2026

FDA Publishes Final Guidance On Human Factors Information
Final guidance slightly narrows scope of which submissions require validation data for user interface risk testing.
Medtech Insight - May 28, 2026

Da Vinci Gets Smarter: Intuitive Announces Numerous Updates For Its Surgical Robot
Intuitive will soon start rolling out more than 100 updates and user experience improvements to its da Vinci 5 surgical robot. The innovations to the already advanced robotic system include expanded visibility, enhanced communications, remote capabilities and improvements to its simulation platform.
Medtech Insight - May 28, 2026

Stability Is No Longer Enough: EU Medtech Faces A Strategic Reckoning On Trade
MedTech Europe directors Diana Kanecka and Jesús Rueda sat down with In Vivo at MedTech Forum 2026 to survey the global medtech landscape and discuss whether it remains one of opportunity for European manufacturers and exporters.
In Vivo - May 28, 2026

Henlius Doses First Subcutaneous Daratumumab Patient
Shanghai Henlius has dosed the first Chinese patient in its global Phase I trial of HLX15-SC, advancing its subcutaneous Darzalex biosimilar program as it targets a multibillion-dollar multiple myeloma franchise.
Generics Bulletin - May 28, 2026

Quotables: Pharma Leaders On The Month’s Hot Topics
The highlights of recent comments and insights from industry executives on the key issues covered in Scrip.
Scrip - May 28, 2026

Haleon UK Expands Into Warming Products With VoltaHeat Range
Haleon expands the Voltarol family into non-medicated warming products, helping tap into consumer demand for “topical warming products that fit seamlessly into active lifestyles.”
HBW Insight - May 28, 2026

Urgo Plans Investments As It Breaks €1bn Barrier
Boosted by a strong performance in the US, France's Urgo has surpassed €1bn in sales for the first time. To maintain this trajectory the company is planning an investment of €150m to strengthen key capabilities in its home market.
HBW Insight - May 28, 2026

Precision HBV Data Add Early Support For Direct cccDNA Targeting Approach
The company presented new data to strengthen the case for direct cccDNA targeting in chronic hepatitis B, an area long viewed as one of the field’s central scientific challenges.
Scrip - May 28, 2026

Sanofi Sees Light At The End Of The Tunnel For Venglustat
Once a pipeline-in-a-product hopeful, the novel drug looks set for an approval decision by the end of the year in the most common type of Gaucher’s disease, following a string of clinical setbacks in other indications.
Scrip - May 28, 2026

Hims & Hers Positions Apotex’s Semaglutide As A Weight Loss Drug In Canada
Online health platform Hims & Hers will sell Apotex’s generic semaglutide in Canada but is only offering off-label prescriptions for weight loss.
Generics Bulletin - May 28, 2026

EMS Readies Synthetic Semaglutide Launch ‘Within Weeks’
Major Brazilian player is closing in on the commercial debut of its follow-on semaglutide product following recent Anvisa approval, with packaging, pricing and production strategy all in focus.
Generics Bulletin - May 28, 2026

Sun’s Organon Deal Won’t Dim Generics Commitment
Sun Pharma insists generics remain attractive despite US pressure and the rising scale of its Innovative Medicines unit, while arguing its $11.75bn Organon deal adds complementary scale in biosimilars, established brands and women’s health.
Generics Bulletin - May 28, 2026

A CAR-T Claim That Could Change Cancer Care — If This Boston-Delhi Biotech Can Pull It Off
Tata Sons-backed MedTherapy claims ultra-fast CAR-T manufacturing, with costs lower by over 70% versus general industry norms. Cipla is partnering with the biotech for one of its early-stage co-developed CAR-Ts.
Scrip - May 28, 2026

EU Digital Negotiations Heading In Wrong Direction, Medtech Sector Says
Joint statement from MedTech Europe and other industry associations says draft compromise text for the Digital Omnibus “undermines” simplification ambitions.
Medtech Insight - May 28, 2026

GSK’s Bepirovirsen Delivers 19% Functional Cure Rate Ahead Of US FDA Decision
GSK confirms a 19% functional cure rate for bepirovirsen in hepatitis B, as the drug heads toward an October US FDA decision.
Scrip - May 28, 2026

The Changing Scene For University Biotech Spinoffs In China
Shanghai-based Degron Therapeutics' co-founder Yong Cang sat down with Scrip to talk about the reasons that more professors in Chinese universities are now setting up biotechs, the genesis of Degron and the differences between the first and second booms in China’s biotech sector.
Scrip - May 28, 2026